TRANSGENE BIOTEK LTD.
Latest filings
- Statutory auditor resigns; replacement appointed to fill casual vacancy · Management Changes
- Statutory auditor Harish Gummadi and Co resigns before term completion · Management Changes
- Statutory auditor resigns; Harish Gummadi and Co appointed to fill vacancy · Management Changes
Snapshot
What the business is, and whether it's a good one at a fair price.
A Healthcare Services company listed on BSE, reporting revenue of ₹0 Cr over the trailing twelve months.
Scorecard
Measured from the filed financials, judged against its Healthcare Service Provider peers · as of FY26 — not investment advice
Strengths
Concerns
Charts
How has the market priced it — with filings on the timeline?
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Peers
How does it stack up on valuation, returns and growth?
Loading peers…
Financials
Quarterly & annual P&L, balance sheet, cash flow, ratios and segments.
Loading financials…
Ownership
Who owns it — and is the promoter stake clean?
Loading shareholding…
Sign up to see the full company file
Governance, sustainability, compliance, earnings calls, presentations, events, reactions and the full filings feed — free with an account.
Common questions
Answered from TRANSGENE BIOTEK LTD.'s filed financials and exchange disclosures
What does TRANSGENE BIOTEK LTD. do?
TRANSGENE BIOTEK LTD. is a Healthcare Services company listed on BSE.
Is TRANSGENE BIOTEK LTD. profitable?
No. Over the trailing twelve months TRANSGENE BIOTEK LTD. reported a net loss of ₹1.61 Cr on revenue of ₹0.22 Cr.
Does TRANSGENE BIOTEK LTD. pay a dividend?
Not in the latest reported year — TRANSGENE BIOTEK LTD.'s dividend payout for FY26 was nil.
Is TRANSGENE BIOTEK LTD. debt-free?
No. It reported borrowings of ₹17 Cr on its 31 Mar 2026 balance sheet, or net debt of ₹17 Cr after cash. Debt stands at 2.05× equity. That is higher than 100% of its 23 Healthcare Service Provider peers.
Is TRANSGENE BIOTEK LTD. expensive compared with its peers?
On trailing P/E, TRANSGENE BIOTEK LTD. ranks 24 of 25 in Healthcare Service Provider — cheaper than 4% of them, against an industry median of 33.9×. This is a position, not a valuation judgement.
How much does the TRANSGENE BIOTEK LTD. share price move in a day?
On a typical session TRANSGENE BIOTEK LTD. moves 2.56% — that is the median absolute close-to-close move across its last 267 trading days. MarketPing measures each filing's price reaction against it.
Where can I track TRANSGENE BIOTEK LTD.'s announcements?
Every NSE and BSE filing by TRANSGENE BIOTEK LTD. appears on this page, AI-summarised, alongside the price reaction that followed it. Follow the company to get each new filing on WhatsApp within minutes.
Figures are as last reported and may lag the latest filing. Not investment advice.